Clinical Trials Sponsored by Huntsman Cancer Institute/ University of Utah

Total 5961 results

M.D. Anderson Cancer Center
National Cancer Institute (NCI); University of Texas

Completed

Nuclear and Near-Infrared (NIR) Imaging in Melanoma

Melanoma

United States
Children's Hospital Medical Center, Cincinnati
The University of Texas Health Science Center, Houston; Tulane University; University...

Completed

Recovery After Stress Toolkit (ReSeT): Pilot Study (ReSeT)

Post-traumatic Stress Disorder

United States
New York Medical College
Johns Hopkins University; M.D. Anderson Cancer Center; Baylor College of Medicine and other collaborators

Terminated

Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma

Hodgkins Lymphoma

United States
University of South Carolina
National Heart, Lung, and Blood Institute (NHLBI); Temple University; University... and other collaborators

Recruiting

Implementing and Evaluating the Integration of Physical Activity Into a Major Health System and Connecting Patients to Physical Activity Programs.

Physical Activity | Chronic Disease | Exercise

United States
Vanderbilt University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

The Impact of Non-Routine Events on Neonatal Safety

Neonatology

United States
University of Maryland, Baltimore
National Cancer Institute (NCI); University of Maryland Greenebaum Cancer Center

Completed

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers

Myelodysplastic Syndromes | Leukemia

United States
University of Utah
National Heart, Lung, and Blood Institute (NHLBI); National Institute of Nursing... and other collaborators

Completed

Facilitating Patient Communication During Noninvasive Ventilation

Noninvasive Ventilation | Speech Intelligibility

United States
Intermountain Health Care, Inc.
National Heart, Lung, and Blood Institute (NHLBI); University of Utah

Recruiting

Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH) (TEACH)

Respiration, Artificial

United States
David Bushnell
National Cancer Institute (NCI); National Institutes of Health (NIH); Holden...

Active, not recruiting

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Neuroendocrine Tumor Gastrointestinal, Hormone-Secreting | Neuroendocrine Tumor, Malignant

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Recruiting

Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study

Colon Adenocarcinoma

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Recruiting

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Breast Cancer | Risk Reduction

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Unknown

Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations (AIMSS)

Colorectal Cancer

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI); University of Southern California; University... and other collaborators

Completed

Study of Gene Modified Immune Cells in Patients With Advanced Melanoma (F5)

Metastatic Melanoma

United States
National Cancer Institute (NCI)
Vanderbilt University

Completed

PRelationship Between Physical Activity and Cancer Ris

Cancer

United States, China
Jennifer Bogner, PhD, ABPP
Patient-Centered Outcomes Research Institute; University of Utah

Completed

Comparative Effectiveness of Rehabilitation Interventions for Traumatic Brain Injury (TBI-CER)

Brain Injuries
Washington University School of Medicine
National Heart, Lung, and Blood Institute (NHLBI); Utah State University

Completed

Phytosterols, Ezetimibe, and Cholesterol Metabolism (Phyteaux-III)

Hypercholesterolemia | Coronary Heart Disease

United States
Patrick Y. Wen, MD
M.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaborators

Completed

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

Glioblastoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); University of Pennsylvania; Washington University... and other collaborators

Completed

TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors

Endometrial Cancer

United States
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH); University of Utah; uBiome; Recovery...

Completed

Binge-Eating Genetics Initiative (BEGIN) - Dynamical Systems Approach (BEGIN)

Binge-Eating Disorder | Bulimia Nervosa

United States
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Dana-Farber Cancer Institute; University of Pittsburgh

Completed

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Advanced Gastrointestinal Stromal Tumor (GIST)

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH); Rockefeller...

Completed

Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy

Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center; National Cancer Institute (NCI); University of Oklahoma

Recruiting

Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS (ProjectENDIT)

Smoking Cessation | HIV

Cambodia
University of Kansas Medical Center
National Cancer Institute (NCI)

Recruiting

Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Metastatic Cholangiocarcinoma | Locally Advanced Cholangiocarcinoma | Stage III Hilar Cholangiocarcinoma AJCC v8 | Stage IV Hilar Cholangiocarcinoma AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Recurrent Cholangiocarcinoma

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Recruiting

Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions (RE-TOOL)

Obesity | Obesity, Morbid

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Completed

LY353381 in Preventing Breast Cancer in Women With Hyperplasia

Breast Cancer

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Completed

Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women

Breast Cancer

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Completed

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

Breast Cancer

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Completed

Rural Women Connecting for Better Health

Obesity | Breast Cancer

United States
Clinical Innovations, LLC
University of Utah; Midwestern University; The Reading Hospital and Medical Center

Completed

Analysis of ROM Plus to Detect Rupture of Membranes

Rupture of Amniotic Membranes

United States
Virginia Commonwealth University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Unknown

Activity for Diabetic Polyneuropathy (ADAPT)

Diabetic Neuropathy

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); University of Miami; University of Florida

Recruiting

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Pancreatic Cancer | Pancreatic Cyst

United States
Srinvasan Beddhu
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...

Recruiting

Sit Less, Interact and Move More (SLIMM) 2 Study

Obesity | Chronic Kidney Diseases

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

Stage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Completed

KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice (KANSURVIVE)

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Completed

Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer

Breast Cancer

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Completed

Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer

Breast Cancer

United States
Yusuf Menda
National Cancer Institute (NCI); National Institutes of Health (NIH); Holden...

Not yet recruiting

A Safety Study of 212Pb-Pentixather Radioligand Therapy

Carcinoid Tumor Lung | Neuroendocrine Tumor of the Lung | Carcinoma, Small-Cell Lung

United States
Sandeep Laroia
National Cancer Institute (NCI); National Institutes of Health (NIH); Holden...

Terminated

Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases

Neuroendocrine Tumors

United States
Yusuf Menda
National Cancer Institute (NCI); National Institutes of Health (NIH); Holden...

Active, not recruiting

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

United States
University of Texas Southwestern Medical Center
National Cancer Institute (NCI); Baylor College of Medicine; University of Pennsylvania and other collaborators

Recruiting

National Liver Cancer Screening Trial (TRACER)

Liver Cirrhosis | Hepatitis B | Carcinoma, Hepatocellular | Liver Cancer

United States
University of Alabama at Birmingham
National Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington... and other collaborators

Completed

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas (Protocol 102)

Neurofibromatosis Type 1

United States
Fred Hutchinson Cancer Research Center/University...
National Cancer Institute (NCI)

Completed

Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission

Adult Acute Lymphoblastic Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia

United States
Fred Hutchinson Cancer Research Center/University...
National Cancer Institute (NCI)

Withdrawn

Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis

Systemic Scleroderma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); University of South Florida

Recruiting

Improving Care After Inherited Cancer Testing (IMPACT)

Breast Cancer | Colorectal Cancer | Prostate Cancer | Endometrial Cancer | Inherited Cancer Syndrome

United States
University of Texas Southwestern Medical Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas

Malignant Gliomas | Astrocytomas | Oligodendrogliomas

United States
Massachusetts General Hospital
St. Jude Children's Research Hospital; University of Utah; American Cancer Society...

Completed

Developing a Health Insurance Navigation Program for Survivors of Childhood Cancer (HINT)

Childhood Cancer Survivors | Health Insurance

United States
Abramson Cancer Center of the University of Pennsylvania
University of Pittsburgh; Rutgers Cancer Institute of New Jersey

Completed

Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma

United States
Fred Hutchinson Cancer Research Center/University...
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
Fred Hutchinson Cancer Research Center/University...
National Cancer Institute (NCI)

Withdrawn

Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease

Graft Versus Host Disease

United States
Fred Hutchinson Cancer Research Center/University...
National Cancer Institute (NCI)

Completed

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Depression | Fatigue | Primary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone... and other conditions

United States

Clinical Trials Sponsored by Huntsman Cancer Institute/ University of Utah

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations